Product Information
KISQALI 600 MG DAILY DOSE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $289.7167 per EA under NDC 00078087463. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
200 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078087463
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
RIBOCICLIB SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA209092On Market Since
3/13/2017
Pharmacological Classes
Price Statistics
The NADAC for KISQALI 600 MG DAILY DOSE has been published 80 times since Dec 18, 2024, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $289.7167 per EA |
|---|---|
| All-time high | $292.6762 (Dec 10, 2025) |
| All-time low | $270.9964 (Dec 18, 2024) |
| 52-week high | $292.6762 |
| 52-week low | $289.7167 |
| Median price | $292.6762 |
| Average price | $290.4447 |
| Largest weekly change | +8.0% (Jan 22, 2025) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of KISQALI 600 MG DAILY DOSE?
The current National Average Drug Acquisition Cost (NADAC) for KISQALI 600 MG DAILY DOSE, manufactured by Novartis Pharmaceuticals Corporation, is $289.7167 per EA (NDC 00078087463), effective Jun 24, 2026.
How has the price of KISQALI 600 MG DAILY DOSE changed over time?
Over the history we have for it, the NADAC for KISQALI 600 MG DAILY DOSE has risen 6.9%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for KISQALI 600 MG DAILY DOSE?
Since Dec 18, 2024, the NADAC for KISQALI 600 MG DAILY DOSE has ranged from a low of $270.9964 (Dec 18, 2024) to a high of $292.6762 (Dec 10, 2025), with a median of $292.6762 per EA.
Are there cheaper alternatives to KISQALI 600 MG DAILY DOSE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as KISQALI 600 MG DAILY DOSE, but none are currently priced below it.
Who manufactures KISQALI 600 MG DAILY DOSE?
KISQALI 600 MG DAILY DOSE (NDC 00078087463) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification